Silva Pharmaceuticals (DHA:SILVAPHL) ROCE % : 0.00% (As of . 20)

View and export this data going back to 2018. Start your Free Trial

What is Silva Pharmaceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Silva Pharmaceuticals's annualized ROCE % for the quarter that ended in . 20 was 0.00%.

Silva Pharmaceuticals ROCE % Historical Data

The historical data trend for Silva Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silva Pharmaceuticals ROCE % Chart

Silva Pharmaceuticals Annual Data

Trend

ROCE %

Silva Pharmaceuticals Semi-Annual Data

ROCE %

Silva Pharmaceuticals ROCE % Calculation

Silva Pharmaceuticals's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

Silva Pharmaceuticals's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

(1) Note: The EBIT data used here is one times the annual (. 20) EBIT data.

Silva Pharmaceuticals (DHA:SILVAPHL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Silva Pharmaceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of Silva Pharmaceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Silva Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silva Pharmaceuticals Ltd (DHA:SILVAPHL) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Road No 8/A New, House No 65, Dhanmondi, Dhaka, BGD, 1209

Website

https://www.silvapharma.com

Silva Pharmaceuticals Ltd is engaged in the manufacturing and marketing of pharmaceuticals finished products. The products are manufactured in the categories of Antibiotics, Analgesics, Antidiabetics, Narcotics, Anti pyretic, Antiinflammatory Drugs, Anti ulcerates, Antiemetic, Gastroprokinetic, Antihistamine, Antispasmodic expectorants, Vitamins, and Minerals medicines. The products are sold in the local market of Bangladesh.

Silva Pharmaceuticals Headlines

No Headlines